Studies open voor deelname
Diabetes mellitus type 2
CONFIDENCE:
Een dubbelblinde fase 2-studie met behandeling in drie parallelgroepen ter beoordeling van de werkzaamheid en veiligheid van finerenone plus empagliflozine in vergelijking met finerenone of empagliflozine bij deelnemers met chronische nierziekte en diabetes type 2.
Toekomstige studies
Diabetes mellitus type 2
FINE-REAL:
A non-interventional study providing insights into the use of finerenone in a routine clinical setting
Zwangerschapsdiabetes
SERENA:
Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes:
a double blind RCT
Obesitas
Boehringer Ingelheim protocol 1404-0038
A Phase III, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity
without type 2 diabetes
Boehringer Ingelheim protocol 1404-0041: obesitas + T2DM
A Phase III, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and
type 2 diabetes mellitus
Contact studieteam
Rina Talpe t 051 23 75 11
Laura Tanghe t 051 23 73 25
Els Verbruggen t 051 23 39 04